Hepatitis B virus;
Resveratrol;
miR-155;
Autophagy;
Virus replication;
ACTIVATION;
D O I:
10.1159/000525807
中图分类号:
Q93 [微生物学];
学科分类号:
071005 ;
100705 ;
摘要:
Introduction: Hepatitis B virus (HBV) infection is a disease with high incidence and lack of effective treatment. In this study, we further explored the mechanism of resveratrol (RVT) in the inhibition of HBV replication. The effects of RVT on HBV replication were verified using in vitro and in vivo experiments. Methods: HepG2 and HepG2.2.15 cell lines were cultured in vitro, and different concentrations of RVT were used to determine its effect on the proliferation of the two cell lines. Autophagy agonists and inhibitors were given, and whether RVT exerts its effect on the proliferation of HepG2 and HepG2.2.15 cells through autophagy was determined. Reverse transcription-quantitative polymerase chain reaction and Western blot were used to detect changes in autophagy-related factors LC3-II, LC3-I, Beclin 1, and p62. Through transfection of pmiR-155, shmiR-155, and the corresponding control group, the relevant mechanism of RVT in inhibiting the proliferation of HepG2 and HepG2.2.15 cells was analyzed. RVT inhibited the toxicity for HepG2.2.15 cells and reduced HBV replication in vitro (p < 0.05). This effect of RVT was enhanced by rapamycin (RAPA; autophagy activator; p < 0.05) but was partially reversed by 3-MA (autophagy inhibitor; p < 0.05). In addition, our results showed that miR-155 expression was higher in HepG2.2.15 cells than in HepG cells (p < 0.05). miR-155 expression in the RVT treatment group was significantly reduced (p < 0.05). We designed an miR-155 overexpression plasmid, low miR-155 expression plasmid, and the corresponding negative control for transfection and found that transfection of pmiR-155 can partially reverse the effect of RVT (p < 0.05), while transfection with shmiR-155 can enhance the effect of RVT (p < 0.05). Discussion: RVT inhibits miR-155, activates autophagy, inhibits the toxicity for HepG2.2.15 cells, and reduces HBV replication, providing a new research direction for the treatment of HBV infection.
机构:
Beijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R ChinaBeijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R China
Yang, Jing
Zhu, Xiangqian
论文数: 0引用数: 0
h-index: 0
机构:
Beijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R China
Tradit Chinese Med Henan Univ, Zhengzhou 450003, Peoples R ChinaBeijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R China
Zhu, Xiangqian
Liu, Juan
论文数: 0引用数: 0
h-index: 0
机构:
Beijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R ChinaBeijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R China
Liu, Juan
Ding, Xiaoran
论文数: 0引用数: 0
h-index: 0
机构:
Beijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R ChinaBeijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R China
Ding, Xiaoran
Han, Mingming
论文数: 0引用数: 0
h-index: 0
机构:
Beijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R ChinaBeijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R China
Han, Mingming
Hu, Wei
论文数: 0引用数: 0
h-index: 0
机构:
Beijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R ChinaBeijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R China
Hu, Wei
Wang, Xuejun
论文数: 0引用数: 0
h-index: 0
机构:
Beijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R ChinaBeijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R China
Wang, Xuejun
Zhou, Zhe
论文数: 0引用数: 0
h-index: 0
机构:
Beijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R ChinaBeijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R China
Zhou, Zhe
Wang, Shengqi
论文数: 0引用数: 0
h-index: 0
机构:
Beijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R ChinaBeijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R China
机构:
Jiangnan Univ, Sch Life Sci & Hlth Engn, Wuxi 214126, Peoples R China
Suzhou Hepa Thera Biopharmaceut Co Ltd, Shanghai 200120, Peoples R ChinaJiangnan Univ, Sch Life Sci & Hlth Engn, Wuxi 214126, Peoples R China
Zhang, Zhipeng
Ma, Yanqin
论文数: 0引用数: 0
h-index: 0
机构:
Suzhou Hepa Thera Biopharmaceut Co Ltd, Shanghai 200120, Peoples R ChinaJiangnan Univ, Sch Life Sci & Hlth Engn, Wuxi 214126, Peoples R China
Ma, Yanqin
He, Yan
论文数: 0引用数: 0
h-index: 0
机构:
Suzhou Hepa Thera Biopharmaceut Co Ltd, Shanghai 200120, Peoples R ChinaJiangnan Univ, Sch Life Sci & Hlth Engn, Wuxi 214126, Peoples R China
He, Yan
Wang, Dong
论文数: 0引用数: 0
h-index: 0
机构:
Suzhou Hepa Thera Biopharmaceut Co Ltd, Shanghai 200120, Peoples R ChinaJiangnan Univ, Sch Life Sci & Hlth Engn, Wuxi 214126, Peoples R China
Wang, Dong
Yue, Kun
论文数: 0引用数: 0
h-index: 0
机构:
Suzhou Hepa Thera Biopharmaceut Co Ltd, Shanghai 200120, Peoples R ChinaJiangnan Univ, Sch Life Sci & Hlth Engn, Wuxi 214126, Peoples R China
Yue, Kun
Zhang, Xiaomei
论文数: 0引用数: 0
h-index: 0
机构:
Jiangnan Univ, Sch Life Sci & Hlth Engn, Wuxi 214126, Peoples R ChinaJiangnan Univ, Sch Life Sci & Hlth Engn, Wuxi 214126, Peoples R China
Zhang, Xiaomei
Song, Huaien
论文数: 0引用数: 0
h-index: 0
机构:
Suzhou Hepa Thera Biopharmaceut Co Ltd, Shanghai 200120, Peoples R ChinaJiangnan Univ, Sch Life Sci & Hlth Engn, Wuxi 214126, Peoples R China